Hugo joined MVM in 2005. Before joining MVM, he qualified as a chartered accountant with KPMG. Hugo has a degree in Molecular and Cellular Biochemistry from Oxford University.

Hugo is a member of the boards of SkyCell AG, Gynesonics, Inc, and Nalu Medical, Inc.

He was previously a director of Vertos Medical, Inc (acquired by Stryker), Horizon Discovery Limited (LSE: HZD, acquired by PerkinElmer), Accuvein, Inc, eZono AG and Vantia Limited, and he led MVM’s investment into BioVex Limited (acquired by Amgen).

Latest news